Insider Selling: Elevance Health (NYSE:ELV) Director Sells 151 Shares of Stock
by Michael Walen · The Markets DailyElevance Health, Inc. (NYSE:ELV – Get Free Report) Director Robert Dixon, Jr. sold 151 shares of the stock in a transaction that occurred on Thursday, June 11th. The shares were sold at an average price of $401.77, for a total transaction of $60,667.27. Following the transaction, the director owned 10,734 shares in the company, valued at $4,312,599.18. The trade was a 1.39% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
Elevance Health Trading Up 1.1%
Shares of NYSE:ELV traded up $4.56 during trading on Friday, reaching $403.74. 1,551,017 shares of the company traded hands, compared to its average volume of 1,835,194. The firm has a market capitalization of $87.68 billion, a price-to-earnings ratio of 17.17, a P/E/G ratio of 2.29 and a beta of 0.67. Elevance Health, Inc. has a 52-week low of $273.71 and a 52-week high of $426.98. The company has a current ratio of 1.48, a quick ratio of 1.48 and a debt-to-equity ratio of 0.70. The business’s fifty day moving average is $364.53 and its 200-day moving average is $344.44.
Elevance Health (NYSE:ELV – Get Free Report) last announced its quarterly earnings results on Wednesday, April 22nd. The company reported $12.58 EPS for the quarter, topping analysts’ consensus estimates of $10.74 by $1.84. The company had revenue of $49.49 billion during the quarter, compared to analyst estimates of $48.21 billion. Elevance Health had a return on equity of 15.58% and a net margin of 2.62%.The firm’s revenue was up 1.5% on a year-over-year basis. During the same quarter last year, the firm posted $11.97 earnings per share. Elevance Health has set its FY 2026 guidance at 19.850- EPS. As a group, analysts forecast that Elevance Health, Inc. will post 26.93 EPS for the current year.
Elevance Health Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Thursday, June 25th. Shareholders of record on Wednesday, June 10th will be given a $1.72 dividend. This represents a $6.88 annualized dividend and a yield of 1.7%. The ex-dividend date of this dividend is Wednesday, June 10th. Elevance Health’s dividend payout ratio (DPR) is presently 29.26%.
Analyst Upgrades and Downgrades
Several research analysts have issued reports on ELV shares. Bank of America raised their target price on Elevance Health from $435.00 to $460.00 and gave the stock a “buy” rating in a research report on Thursday, June 4th. Evercore reaffirmed a “hold” rating on shares of Elevance Health in a research report on Tuesday, May 19th. JPMorgan Chase & Co. lifted their price objective on Elevance Health from $411.00 to $476.00 and gave the company an “overweight” rating in a research report on Monday. Leerink Partners set a $364.00 price objective on Elevance Health in a research report on Thursday, April 23rd. Finally, Jefferies Financial Group lowered their price objective on Elevance Health from $395.00 to $391.00 and set a “buy” rating on the stock in a research report on Monday, April 20th. Fourteen research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $416.11.
Read Our Latest Analysis on Elevance Health
Institutional Trading of Elevance Health
A number of large investors have recently added to or reduced their stakes in ELV. WealthCollab LLC lifted its stake in shares of Elevance Health by 42.2% during the 1st quarter. WealthCollab LLC now owns 91 shares of the company’s stock worth $27,000 after purchasing an additional 27 shares during the last quarter. Rossby Financial LCC lifted its stake in shares of Elevance Health by 110.0% during the 3rd quarter. Rossby Financial LCC now owns 84 shares of the company’s stock worth $28,000 after purchasing an additional 44 shares during the last quarter. Kemnay Advisory Services Inc. purchased a new stake in shares of Elevance Health during the 4th quarter worth $31,000. J.Safra Asset Management Corp purchased a new stake in shares of Elevance Health during the 4th quarter worth $32,000. Finally, ORG Partners LLC lifted its stake in shares of Elevance Health by 120.4% during the 4th quarter. ORG Partners LLC now owns 108 shares of the company’s stock worth $38,000 after purchasing an additional 59 shares during the last quarter. Institutional investors own 89.24% of the company’s stock.
About Elevance Health
Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.
Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.